Crossmark

Three-month early change in prostate-specific antigen levels as a predictive marker for overall survival during hormonal therapy for metastatic hormone-sensitive prostate cancer

Crossref DOI link: https://doi.org/10.1186/s13104-021-05641-5

Published Online: 2021-06-03

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakanishi, Shotaro http://orcid.org/0000-0002-0117-9490
Goya, Masato

Tamaki, Mitsuyoshi

Oshiro, Takuma

Saito, Seiichi
License Information

Text and Data Mining valid from 2021-06-03

Version of Record valid from 2021-06-03
More Information

Article History

Received: 12 January 2021

Accepted: 27 May 2021

First Online: 3 June 2021

Declarations

:

: The present study was approved by the internal institutional review board of the University of the Ryukyus (Approval Number: 1341). This was a retrospective study, and informed consent was not required by the board.

: The data do not contain any information that could identify the patient, therefore consent for publication was waived.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below